Product Details
| Product Name:
Etilevodopa |
CAS No.:
37178-37-3 |
| Supply Ability:
10g |
Release date:
2026/04/22 |
Product Introduction
Bioactivity
| Name | Etilevodopa |
| Description | Etilevodopa is an ethyl-ester prodrug of Levodopa which is used for the treatment of Parkinson's disease (PD). It is rapidly hydrolyzed to Levodopa and ethanol by nonspecific esterases in the gastrointestinal tract. Levodopa is the direct precursor of dopamine. |
| In vitro | Etilevodopa passes unchanged through the stomach to the duodenum and is subsequently absorbed into the bloodstream as Levodopa [1]. Etilevodopa has a greater solubility in the stomach, faster passage to the small intestine, and a shortened time to maximum Levodopa concentration, compared with standard Levodopa [2]. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Shipping with blue ice/Shipping at ambient temperature. |
| Keywords | Etilevodopa |
| Inhibitors Related | H-ASP-PHE-OH | 2-(Methylamino)benzoic acid | Melamine | Mycophenolate Mofetil | Hexamethonium Bromide | Octopamine hydrochloride | L-DOPA | 10-Undecen-1-ol | Isonicotinic acid | Urolithin A | Lansoprazole sulfide | 4-(4-Amino-3-fluorophenoxy)-N-methylpicolinamide |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
Recommended supplier
| Product name |
Price |
|
Suppliers |
Update time |
|
|
$48.00
|
VIP6Y
|
TargetMol Chemicals Inc.
|
2026-05-11 |
United States